[1]
|
Tu, W.J., Wang, L.D. and Special Writing Group of China Stroke Surveillance R (2023) China Stroke Surveillance Re-port 2021. Military Medical Research, 10, Article No. 33. https://doi.org/10.1186/s40779-023-00463-x
|
[2]
|
Mushenkova, N.V., Summerhill, V.I., Zhang, D., et al. (2020) Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque. International Journal of Molecular Sciences, 21, Article No. 2992. https://doi.org/10.3390/ijms21082992
|
[3]
|
Zhu, Y., Xian, X., Wang, Z., et al. (2018) Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules, 8, Article No. 80. https://doi.org/10.3390/biom8030080
|
[4]
|
Singh, S.K. and Agrawal, A. (2019) Functionality of C-Reactive Protein for Atheroprotection. Frontiers in Immunology, 10, Article No. 1655. https://doi.org/10.3389/fimmu.2019.01655
|
[5]
|
Sun, H., Koike, T., Ichikawa, T., et al. (2005) C-Reactive Protein in Atherosclerotic Lesions: Its Origin and Pathophysiological Significance. The American Journal of Pathology, 167, 1139-1148.
https://doi.org/10.1016/S0002-9440(10)61202-3
|
[6]
|
Nguyen, M.T., Fernando, S., Schwarz, N., et al. (2019) In-flammation as a Therapeutic Target in Atherosclerosis. Journal of Clinical Medicine, 8, Article No. 1109. https://doi.org/10.3390/jcm8081109
|
[7]
|
Rose-John, S. (2020) Interleukin-6 Signalling in Health and Disease. F1000Research, 9, 1013.
https://doi.org/10.12688/f1000research.26058.1
|
[8]
|
Tanaka, T., Narazaki, M. and Kishimoto, T. (2014) IL-6 in In-flammation, Immunity, and Disease. Cold Spring Harbor Perspectives in Biology, 6, a016295. https://doi.org/10.1101/cshperspect.a016295
|
[9]
|
Chen, J., Wang, W., Ni, Q., et al. (2022) Interleukin 6-Regulated Macrophage Polarization Controls Atherosclerosis-Associated Vascular Intimal Hyperplasia. Frontiers in Immunology, 13, Article ID: 952164.
https://doi.org/10.3389/fimmu.2022.952164
|
[10]
|
Su, J.H., Luo, M.Y., Liang, N., et al. (2021) Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. Frontiers in Pharmacology, 12, Article ID: 745061. https://doi.org/10.3389/fphar.2021.745061
|
[11]
|
Gonzalez, L.L., Garrie, K. and Turner, M.D. (2020) Role of S100 Proteins in Health and Disease. BBA Molecular Cell Research, 1867, Article ID: 118677. https://doi.org/10.1016/j.bbamcr.2020.118677
|
[12]
|
Donato, R., Cannon, B.R., Sorci, G., et al. (2013) Functions of S100 Proteins. Current Molecular Medicine, 13, 24-57.
https://doi.org/10.2174/156652413804486214
|
[13]
|
Zhou, Y., Zha, Y., Yang, Y., et al. (2023) S100 Proteins in Cardiovascular Diseases. Molecular Medicine, 29, Article No. 68. https://doi.org/10.1186/s10020-023-00662-1
|
[14]
|
Croce, K. (2010) S100A8/A9 Complex: More than Just a Bi-omarker of Cardiovascular Risk? Circulation Journal, 74, 626-627. https://doi.org/10.1253/circj.CJ-10-0192
|
[15]
|
Endo, Y., Fujita, M. and Ikewaki, K. (2023) HDL Functions-Current Status and Future Perspectives. Biomolecules, 13, Article No. 105. https://doi.org/10.3390/biom13010105
|
[16]
|
Adorni, M.P., Ronda, N., Bernini, F., et al. (2021) High Density Lip-oprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives. Cells, 10, Article No. 574. https://doi.org/10.3390/cells10030574
|
[17]
|
Lutjohann, D., Klor, H.U. and Stellaard, F. (2023) Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations. Nutrients, 15, Article No. 2202. https://doi.org/10.3390/nu15092202
|
[18]
|
Wu, Z., Li, X., Wen, Q., et al. (2022) Serum LDL-C/HDL-C Ratio and the Risk of Carotid Plaques: A Longitudinal Study. BMC Cardiovascular Disorders, 22, Article No. 501. https://doi.org/10.1186/s12872-022-02942-w
|
[19]
|
Li, T.D. and Zeng, Z.H. (2018) Adiponec-tin as a Potential Therapeutic Target for the Treatment of Restenosis. Biomedicine & Pharmacotherapy, 101, 798-804. https://doi.org/10.1016/j.biopha.2018.03.003
|
[20]
|
Choi, H.M., Doss, H.M. and Kim, K.S. (2020) Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases. International Journal of Molecular Sciences, 21, Arti-cle No. 1219. https://doi.org/10.3390/ijms21041219
|
[21]
|
Barseghian, A., Gawande, D. and Bajaj, M. (2011) Adi-ponectin and Vulnerable Atherosclerotic Plaques. Journal of the American College of Cardiology, 57, 761-770. https://doi.org/10.1016/j.jacc.2010.11.011
|
[22]
|
Denver, R.J., Bonett, R.M. and Boorse, G.C. (2011) Evolution of Leptin Structure and Function. Neuroendocrinology, 94, 21-38. https://doi.org/10.1159/000328435
|
[23]
|
Katsiki, N., Mikhailidis, D.P. and Banach, M. (2018) Leptin, Cardiovascular Diseases and Type 2 Diabetes Mellitus. Acta Pharma-cologica Sinica, 39, 1176-1188. https://doi.org/10.1038/aps.2018.40
|
[24]
|
Liu, S., Cui, F., Ning, K., et al. (2022) Role of Irisin in Physiology and Pathology. Frontiers in Endocrinology (Lausanne), 13, Article ID: 962968. https://doi.org/10.3389/fendo.2022.962968
|
[25]
|
Liu, C., Wei, A. and Wang, T. (2022) Irisin, an Effective Treat-ment for Cardiovascular Diseases? Journal of Cardiovascular Development and Disease, 9, Article No. 305. https://doi.org/10.3390/jcdd9090305
|
[26]
|
Byun, K. and Lee, S. (2020) The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review. International Journal of Molecular Sciences, 21, Article No. 7184. https://doi.org/10.3390/ijms21197184
|
[27]
|
Wang, X. and Khalil, R.A. (2018) Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Advances in Pharmacology, 81, 241-330. https://doi.org/10.1016/bs.apha.2017.08.002
|
[28]
|
Florence, J.M., Krupa, A., Booshehri, L.M., et al. (2017) Metal-loproteinase-9 Contributes to Endothelial Dysfunction in Atherosclerosis via Protease Activated Receptor-1. PLOS ONE, 12, e0171427.
https://doi.org/10.1371/journal.pone.0171427
|
[29]
|
Silvello, D., Narvaes, L.B., Albuquerque, L.C., et al. (2014) Serum Levels and Polymorphisms of Matrix Metalloproteinases (MMPs) in Carotid Artery Atherosclerosis: Higher MMP-9 Levels Are Associated with Plaque Vulnerability. Biomarkers, 19, 49-55. https://doi.org/10.3109/1354750X.2013.866165
|
[30]
|
Lu, T.X. and Rothenberg, M.E. (2018) MicroRNA. Journal of Allergy and Clinical Immunology, 141, 1202-1207.
https://doi.org/10.1016/j.jaci.2017.08.034
|
[31]
|
Lu, Y., Thavarajah, T., Gu, W., et al. (2018) Impact of miRNA in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, e159-e170. https://doi.org/10.1161/ATVBAHA.118.310227
|
[32]
|
Laffont, B. and Rayner, K.J. (2017) MicroRNAs in the Pathobiology and Therapy of Atherosclerosis. Canadian Journal of Cardiology, 33, 313-324. https://doi.org/10.1016/j.cjca.2017.01.001
|